John Ioannidis
Publication Details
-
Clinical importance of antibodies against platelet activating factor in antiphospholipid syndrome manifestations.
Eur J Clin Invest. 2000; (7): 646-52
We assessed whether antibodies against platelet activating factor (PAF) are related to the presence of antiphospholipid syndrome (APS) clinical manifestations, in particular thrombosis, in patients with connective tissue diseases.
Help